NCT03296917View on ClinicalTrials.gov

Study Examining PrEP-001 in Subjects With Asthma

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 11, 2015

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
Asthma
Interventions
DRUG

PrEP-001

A spray dried powder for intranasal administration formulated from an aqueous mixture of pre-gelatinized waxy maize starch and the drug substance delivered using a single dose nasal powder device.

DRUG

G-004

A spray dried pre-gelatinized waxy maize starch powder (G-001) in the single dose nasal powder device

Sponsors

Lead Sponsor

Hvivo
All Listed Sponsors
collaborator

Prep Biopharm Limited

INDUSTRY

lead

Hvivo

INDUSTRY